Reply to the Editor:  by Grauss, Robert W et al.
Letters to the Editorings is that virtually all valved conduits
except for cellular syngrafts resulted in sig-
nificant sinus thrombus formation. This
limitation of the model used could have
been addressed in part by using a func-
tional model in which blood flow and leaf-
let mobility can be demonstrated.2 The sig-
nificance of sinus thrombosis is not
negligible, and it has been shown to be-
come a nidus for inflammatory cells, po-
tentially affecting neighboring cellular im-
mune responses and any conclusions made
from histologic examination.3,4
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Reply to the Editor:
We thank Le´gare´ and Ross for their com-
ment on our article describing the in vivo
behavior of decellularized rat aortic valve
allografts. As they state in their letter, a
complication of the model we used is the
sinus thrombus formation observed in all
decellularized synergrafts and allografts, as
well as in the untreated allografts. They
speculate that this is due mainly to a lack of
leaflet mobility in a nonfunctional implan-
tation model.1
To overcome this difficulty Le´gare´ and
Ross suggest the use of a functional rat
implantation model in which the creation
156 The Journal of Thoracic and Cardiovaof native aortic valve insufficiency results
in a significant diastolic flow reversal in the
abdominal aorta, allowing leaflets to move
and function.2 Although we were aware of
the existence of this model, we decided not
to use it for our study. One reason is that
the creation of aortic insufficiency results
in progressive congestive heart failure from
volume overload, making the model un-
suitable for long-term follow-up studies. In
addition, a rather high mortality is seen in
the model (62.5% survival). We fully agree
about the importance of having functional
moving leaflets in the bloodstream in
studying aortic valve failure; however, we
look forward to new data that will encour-
age us to incorporate the model in our
future studies.
We respectfully disagree with the as-
sumption that a nonfunctional model is the
main reason for the sinus thrombus forma-
tion. Interestingly, in our study none of the
untreated (cellular) synergrafts displayed
thrombus formation. This is consistent with
earlier results in this model by Oei and
colleagues,1 who showed absence of
thrombus formation in all synergrafts and
even in some allografts. This indicates that
loss of cellular structures, resulting in an
absent blood-tissue barrier, from the
treated synergrafts and allografts and un-
treated allografts is an essential condition
in thrombus formation.
Our study suggests that decellulariza-
tion reduces the recipient’s immune re-
sponse, resulting in a preservation of the
extracellular matrix structure. We therefore
believe in the feasibility of acellular allo-
grafts as scaffolds for tissue-engineering
purposes and are performing seeding ex-
periments at the moment to determine the
best cell source.
Regarding the influence of thrombosis
on the inflammatory response,3 seeding of
acellular valves with autologous endothe-
lium will result in a new blood-tissue bar-
rier and is expected to protect against
thrombus formation. We therefore believe
that this model is suitable for further re-
search in tissue engineering of aortic
valves.
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Which is the best surgical strategy
for “complete” treatment of ischemic
cardiomyopathy?
To the Editor:
We read with great interest the article pub-
lished in the Journal by Maxey and asso-
ciates1 concerning surgery for ischemic
cardiomyopathy. First of all, Maxey and
associates are to be commended for out-
standing results in a challenging cohort of
patients. The study included 14 patients
who underwent mitral valve repair (MVR)
associated with coronary artery bypass
grafting and left ventricular restoration
(LVR), but Maxey and associates1 did not
mention the sequence of the surgical pro-
cedures. In a previous article, they reported
performing coronary artery bypass grafting
first, then MVR, and finally LVR.2
Ischemic mitral regurgitation is a func-
tional disorder that is due mainly to
changes in the geometric relationships be-
tween structurally normal valve compo-
nents and a severely damaged ventricle. By
changing ventricular volume and geome-
try, LVR may unpredictably result in mitral
insufficiency that is absent before surgery3
or in an amelioration (sometimes disap-
pearance) of mitral regurgitation.4 It there-
fore seems more rational to address MVR
after completely rebuilding ventricular ge-
ometry. In addition, this strategy allows
evaluation of valve competence after LVR
and a check on leaflet apposition (in
Bolling and associates’ experience,5 in ad-
dition to the annuloplasty ring 54 of 100
patients required further mitral repairs).
Moreover, after LVR with narrower con-
figuration and papillary muscles realign-
ment, the mitral incompetence may disap-
pear, thus making mitral valve repair
unnecessary. We could speculate that in the
only patient who showed persistent mitral
